Skip to main content
OpenTrials

Clinical trial condition

Hamartoma

Explore clinical trials studying Hamartoma. Study availability and eligibility vary by location and protocol.

108 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Hamartoma trial results

Completed

A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer

NCT00600275

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • Nevada Cancer Center Las Vegas, Nevada, United States
  • Cancer Therapy and Research Center (CTRC) San Antonio, Texas, United States
View Trial Details
Completed

A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer

NCT00620594

Conditions
Advanced Solid Tumors, Breast Cancer, Breast Diseases, +12 more
Locations
  • University of California at Los Angeles JonssonComprehensiveCancerCtr Los Angeles, California, United States
  • Yale University School of Medicine YaleCancerCtr-ClinTrialsOffice New Haven, Connecticut, United States
  • Dana Farber Cancer Institute Clinical Trials ProjectManager Boston, Massachusetts, United States
  • Nevada Cancer Institute NVCC - Huntsman Las Vegas, Nevada, United States
View all 15 locations
View Trial Details
Completed

Topical Rapamycin to Erase Angiofibromas in TSC

NCT01526356

Conditions
Angiofibroma, Angiofibromas, Congenital Abnormalities, +16 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Mattel Children's Hospital Los Angeles, California, United States
  • Jack & Julia Center for TSC at Oakland Children's Hospital & Research Center Oakland, California, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
View Trial Details
Completed

Everolimus for Cancer With TSC1 or TSC2 Mutation

NCT02201212

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Safety of Simvastatin in LAM and TSC

NCT02061397

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Phenotype and Etiology of Pallister-Hall Syndrome

NCT00001404

Conditions
Abnormalities, Multiple, Bone Diseases, Bone Diseases, Developmental, +28 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Greenwood Genetics Center Greenwood, South Carolina, United States
  • Ankara University School of Medicine Ankara, Turkey (Türkiye)
View Trial Details
Completed

Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC

NCT01767779

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Los Angeles, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
View Trial Details

Related conditions